BlackRock Health Sciences Trust (NYSE:BME) Stock Price Breaks Below 50-Day Moving Average – What’s Next?

BlackRock Health Sciences Trust (NYSE:BME)’s stock price passed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $44.63 and traded as low as $42.87. BlackRock Health Sciences Trust shares last traded at $43.93, with a volume of 50,190 shares trading hands.

BlackRock Health Sciences Trust Stock Up 2.2%

The company has a fifty day moving average price of $44.63 and a 200 day moving average price of $41.94.

BlackRock Health Sciences Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Tuesday, December 22nd. Investors of record on Friday, December 11th will be given a dividend of $0.2621 per share. This represents a $3.15 annualized dividend and a yield of 7.2%. The ex-dividend date is Friday, December 11th.

Institutional Trading of BlackRock Health Sciences Trust

Several hedge funds and other institutional investors have recently bought and sold shares of BME. Bank of America Corp DE purchased a new stake in shares of BlackRock Health Sciences Trust during the second quarter valued at approximately $11,827,000. 1607 Capital Partners LLC increased its stake in shares of BlackRock Health Sciences Trust by 49.5% in the fourth quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock worth $9,429,000 after buying an additional 75,958 shares during the period. HBK Sorce Advisory LLC purchased a new position in shares of BlackRock Health Sciences Trust in the second quarter worth $572,000. Cypress Capital Management LLC WY raised its holdings in BlackRock Health Sciences Trust by 18.8% during the 2nd quarter. Cypress Capital Management LLC WY now owns 53,307 shares of the company’s stock valued at $2,290,000 after buying an additional 8,447 shares during the last quarter. Finally, PVG Asset Management Corp bought a new stake in BlackRock Health Sciences Trust during the 1st quarter valued at $251,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company focused on the global health sciences sector. The fund seeks to provide investors with total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in health care and related industries.

Its portfolio may include companies engaged in pharmaceuticals, biotechnology, medical devices, health care services, diagnostics, and other areas supporting the development and delivery of health-related products and services.